An innovative technology is offering men whose prostate cancer recurs after radiation therapy "new hope." According to business correspondent Seth Vogelman, "SeedNet" - a freezing technique used to destroy the diseased prostate gland without damaging the surrounding healthy tissue - is the only option to improve long-term survival in men who experience a recurrence of the disease. The SeedNet technology is marketed in the U.S. by Galil Medical USA. The new technology uses 12 tiny needles that are inserted through a template into the prostate gland, directly through the skin of the perineum; the needles use supercold argon gas to generate patented "IceSeeds" that combine to form a precisely contoured iceball to freeze the diseased tissue and destroy the gland without harming the surrounding healthy tissue.
The unique procedure evenly distributes the cancer-killing "seeds" safely and effectively with minimal invasiveness. Galil says that this makes it the best treatment option for patients who cannot or prefer not to undergo surgery to remove the prostate. Of particular interest is the fact that the new "SeedNet" system is based on technology developed by the Israeli military to cool the infrared devices that guide missiles. Galil Medical, with operations in Israel and the U.S., specializes in the development, manufacture and marketing of state-of-the-art, minimally invasive medical products and systems.
The unique procedure evenly distributes the cancer-killing "seeds" safely and effectively with minimal invasiveness. Galil says that this makes it the best treatment option for patients who cannot or prefer not to undergo surgery to remove the prostate. Of particular interest is the fact that the new "SeedNet" system is based on technology developed by the Israeli military to cool the infrared devices that guide missiles. Galil Medical, with operations in Israel and the U.S., specializes in the development, manufacture and marketing of state-of-the-art, minimally invasive medical products and systems.